Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 14 (HIGD1AP14) is a human pseudogene located on chromosome 4[7]. It is annotated as a processed pseudogene related to the functional HIG1 hypoxia inducible domain family member 1A gene (HIGD1A), which encodes a mitochondrial membrane protein involved in cell response to hypoxia. Unlike HIGD1A, HIGD1AP14 does not encode a functional protein and has no known biological or clinical significance[5][7]. The true protein-coding gene in this family, HIGD1A, is involved in mitochondrial function, apoptosis regulation, and has been implicated in diseases such as heart disease, cancer, and degenerative disorders[2][6]. However, HIGD1AP14 itself is not a functional gene or therapeutic target. HIGD1AP14 is a human pseudogene, not a functional therapeutic target, and carries no known molecular, biological, clinical, or pharmacological relevance as of current knowledge[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 14 (HIGD1AP14).